Propolis Research Centre A/S
A/SActiveCVR 50091015Lille Veksøvej 11, 3670 Veksø SjællandPatent brokering and marketing service activities· NACE 7491Est. 1974 · 52 years old— employees
Loading company…
Overview
Propolis Research Centre A/S is a Danish A/S based in Veksø Sjælland, operating in the Patent brokering and marketing service activities sector. Incorporated in 1974, the company reported a gross profit of DKK 177.7k in its latest annual filing.
Gross profit 2025
177.7K DKK
+32% vs 2024
EBITDA margin (of gross profit)
100.0 %
+32% vs 2024
Net profit 2025
155.6K DKK
+22% vs 2024
Key ratios
See full ratios →Solidity ratioEquity ÷ Total assets × 100
85.9 %
StrongAmong the 30% highest rated companies in the industry
20212025
Liquidity ratioCurrent assets ÷ Short-term debt
12.1×
Very strongAmong the 20% highest rated companies in the industry
20212025
Return on assets (ROA)Net profit ÷ Total assets × 100
20.4 %
StrongAmong the 30% highest rated companies in the industry
20212025
EBITDA — year on year
DKK thousandsKey figures
Annual report 2025| Gross profit | 177.7K DKK | +32% |
| EBITDA | 177.7K DKK | +32% |
| Net profit | 155.6K DKK | +22% |
| Total assets | 763K DKK | +5% |
| Equity | 655.6K DKK | +5% |
| Employees | — | — |
Company information
Legal name
PROPOLIS RESEARCH CENTRE A/S
CVR number
50091015
Legal form
Aktieselskab
NACE code
Founded
10 September 1974 · 52 years
Share capital
DKK 500,000
Employees
—
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Selskabet tegnes af selskabets direktør eller af bestyrelsesformanden i forening med et andet bestyrelsesmedlem eller af den samlede bestyrelse.
Company purpose
Selskabets formål er (1) erhvervsmæssigt at udnytte licenser, ophavsrettigheder, patenter, designs, ceutisk, hemmelige processer eller formler, varemærker og lignende rettigheder, at fremme salg og køb af og - handle med -ovennævnte, herunder at give tilladelse til udnyttelse af sådanne rettigheder og at modtage royaltybetaling og andre indtægter, der er forbundet med disse aktiviteter (2) at erhverve, deltage i, finansiere, administrere og at have andre interesser i andre selskaber eller virksomheder af enhver art, der bidrager eller kan bidrage til ovenstående, alt det foregående i bredeste forstand og herunder enhver aktivitet eller ethvert formål, der er forbundet dermed eller kan bidrage dertil og (3) at udføre forskning for at optimere værdien af propolis råmateriale, propolis vandekstrakt (PVE) eller andre produkter der stammer fra propolis.
(no translation available)
Address
Lille Veksøvej 11, 3670 Veksø Sjælland
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Financial development
In its most recent annual report (2025), Propolis Research Centre A/S reported a gross profit of DKK 177.7k, an increase of 32% on the year before. The figures on this page draw on 5 annual filings covering 2021 to 2025. The bottom line showed a net profit of DKK 155.6k, and the EBITDA margin stood at 100%.
At the end of 2025, equity financed 85.9% of the balance sheet, and current assets covered short-term debt 12.1 times.
Financials
Gross profit
DKK thousandsEBITDA
DKK thousandsIncome statement
DKK thousands| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Gross profit | 178 | 135 | 129 | 315 | 291 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 |
| EBITDA | 178 | 135 | 129 | 315 | 291 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 |
| EBIT | 178 | 135 | 129 | 315 | 291 |
| Net financials | 22 | 28 | 39 | 42 | 40 |
| Profit before tax | 200 | 163 | 168 | 356 | 331 |
| Tax | 44 | 36 | 37 | 78 | 73 |
| Net profit | 156 | 127 | 131 | 278 | 258 |
Get a credit rating – not just the numbers
Financial statements show the past. Risika gives you a score and a recommended credit limit, so you know what the numbers mean for your risk.
Balance sheet
DKK thousands| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | 763 | 724 | 773 | 969 | 891 |
| Equity | 656 | 627 | 631 | 778 | 758 |
| Long-term debt | 44 | 36 | 37 | 0 | 0 |
| Short-term debt | 63 | 60 | 105 | 191 | 133 |
| Total debt | 107 | 96 | 142 | 191 | 133 |
Financial ratios
5-year trendEBITDA margin (of gross profit)
100.0 %
20212025
Equity ratio
85.9 %
StrongAmong the 30% highest rated companies in the industry
20212025
Return on equity
23.7 %
StrongAmong the 40% highest rated companies in the industry
20212025
Net profit margin (of gross profit)
87.6 %
20212025
Asset turnover (of gross profit)
0.23×
20212025
Debt / equity
0.16×
StrongAmong the 30% highest rated companies in the industry
20212025
Sector performance
21 of 28 ratios graded28 financial ratios from the latest filing, each graded against companies in the same industry.
Profitability
Return on equity (ROE)Strong
Among the 40% highest rated companies in the industry
Net profit as a percentage of equity — the return the owners earned on their invested capital this year.
Return on assets (ROA)Strong
Among the 30% highest rated companies in the industry
Net profit as a percentage of total assets — the return generated on the capital employed.
Return on net assets (RONA)Strong
Among the 40% highest rated companies in the industry
Profit relative to net assets (total assets minus total debt) — the ability to generate earnings from the net asset base alone.
Basic earning power (BEP)Strong
Among the 30% highest rated companies in the industry
EBIT relative to total assets — the company's earning power before the effects of tax and financial leverage.
Gross marginNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
The gross result as a share of revenue — how much of the revenue is left after variable costs to cover the company's fixed costs.
Operating marginNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
EBIT as a share of revenue — the share of revenue remaining as earnings once all operating costs are covered. A key measure of earning power.
Net profit marginNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
The profit for the year as a share of revenue — the company's ability to turn revenue into profit.
Capacity ratioNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
Shows how strongly fixed costs weigh on the gross result — a high ratio means fixed costs take only a small bite out of the earnings from basic operations.
Liquidity
Current ratioVery strong
Among the 20% highest rated companies in the industry
Current assets relative to short-term debt — the ability to settle short-term obligations with current assets alone. Around 150% is considered satisfactory from a credit perspective.
Quick ratioVery strong
Among the 20% highest rated companies in the industry
Current assets excluding inventory relative to short-term debt — whether the most liquid assets alone can cover the short-term obligations. A value of 1 or above signals a healthy liquidity position.
Cash ratioVery strong
Among the 20% highest rated companies in the industry
Cash relative to short-term debt — the ability to repay short-term obligations with cash alone.
Current assets to equityAverage
Around the average of companies in the same industry
Current assets relative to equity — an indicator of the balance-sheet structure and of the company's short- and long-term financing. The healthy level is highly industry-dependent.
Fixed assets to long-term capitalVery strong
Among the 10% highest rated companies in the industry
Fixed assets relative to long-term capital (equity plus long-term liabilities). Below 100% means the long-term capital finances more than just the fixed assets — a healthier liquidity position.
Cash conversion ratioAverage
Around the average of companies in the same industry
Cash flow relative to profit — the ability to convert reported profits into accessible cash.
Debt & solvency
Solidity ratioStrong
Among the 30% highest rated companies in the industry
Equity as a share of total assets — the ability to absorb losses. Around 40% is considered satisfactory from a credit perspective.
Debt ratioStrong
Among the 30% highest rated companies in the industry
Total debt relative to the balance-sheet total — the share of the assets financed by debt rather than equity.
Debt to equityStrong
Among the 30% highest rated companies in the industry
Debt relative to equity — the company's leverage. A higher value means heavier reliance on debt financing.
Liabilities to equityStrong
Among the 30% highest rated companies in the industry
Total liabilities relative to equity — whether the company operates primarily on borrowed capital or on its own.
Income to debtVery strong
Among the 20% highest rated companies in the industry
Profit relative to debt — the ability to create earnings while operating with debt.
EBITDA to debtVery strong
Among the 20% highest rated companies in the industry
EBITDA relative to debt — how much operating earnings are available to service the debt.
Interest rate on debtVery strong
Among the 10% highest rated companies in the industry
Financial expenses relative to total liabilities — the effective interest rate the company pays on its debt.
Interest marginStrong
Among the 30% highest rated companies in the industry
The return on assets minus the interest rate on debt. Positive means the company benefits from operating with debt; negative means the debt makes it worse off.
Interest coverageNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
The ability to pay the interest on the company's debt out of its earnings.
Efficiency & development
Equity to contributed capitalWeak
Among the 40% lowest rated companies in the industry
Total equity relative to the capital the owners contributed — how the equity has developed from its starting point.
One-year change in equityAverage
Around the average of companies in the same industry
The size of this year's increase or decrease in the company's equity.
One-year change in debtWeak
Among the 40% lowest rated companies in the industry
The size of this year's increase or decrease in the company's debt.
Asset turnoverNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
Revenue relative to total assets — the ability to generate revenue from the asset base.
Inventory turnoverNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
Revenue relative to inventory — how many times a year the inventory is sold and replaced. A low value can indicate weak sales or excess inventory.
Annual reports & filings
- Annual report 2025Filed via CVR / Virk · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via CVR / Virk · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via CVR / Virk · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via CVR / Virk · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via CVR / Virk · Period 2020-07-01 – 2021-06-30
People & ownership
Management
Actively employed in the business| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
JV Chief Executive Officer | Chief Executive Officer | 1996 |
Board of directors
Non-executive oversight| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
MT Chairman | Chairman | 2009 |
JV Board of Directors | Board of Directors | 1996 |
MT Board of Directors | Board of Directors | 2009 |
JC Board of Directors | Board of Directors | 2009 |
Former (7)
SH Board of Directors | Board of Directors | 1996 – 2004 |
JO Board of Directors | Board of Directors | 2003 – 2007 |
KK Board of Directors | Board of Directors | 2001 – 2009 |
BO Chairman | Chairman | 1996 – 2001 |
JD Board of Directors | Board of Directors | 2003 – 2004 |
HC Board of Directors | Board of Directors | 1974 – 1999 |
GS Chairman | Chairman | 1996 – 1996 |
Shareholders
Active legal owners| Shareholder | Type | Ownership | Votes | Registered |
|---|---|---|---|---|
| Company | 100% | 100% | 1999 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
One in three Danish companies experiences fraud
Sound familiar? See how to strengthen your defences and catch suspicious changes in ownership and management in time.
Related companies
Company hierarchy
JVN HOLDING ApS
Propolis Research Centre A/S Board network connections
Board members of Propolis Research Centre A/S also hold positions in 15 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jan Overgaard | Board of Directors | 9 companiesMany roles |
| Martin Trolle Nielsen | Board of Directors | 2 companies |
| Jens Vagn Nielsen | Chief Executive Officer | 1 company |
| Mona Trolle Nielsen | Chairman | 1 company |
| Karsten Kielland | Board of Directors | 1 company |
| Jens Christian Trolle Nielsen | Board of Directors | 1 company |
Frequently asked questions
What is the CVR number of Propolis Research Centre A/S?
Propolis Research Centre A/S is registered with CVR / Virk under CVR 50091015.
What is the gross profit of Propolis Research Centre A/S?
Propolis Research Centre A/S reported a gross profit of DKK 177.7k in 2025.
Who is the CEO of Propolis Research Centre A/S?
Jens Vagn Nielsen is the CEO of Propolis Research Centre A/S, in role since 1996.
Who is the chairman of Propolis Research Centre A/S?
Mona Trolle Nielsen chairs the board of Propolis Research Centre A/S, in role since 2009.
Where is Propolis Research Centre A/S headquartered?
Propolis Research Centre A/S's registered address is Lille Veksøvej 11.